To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Exuma Biotech grabs $19m Series B
West Palm Beach, Florida-based Exuma Biotech, a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors, has raised $19 million in Series B financing.
